# Japan Structural Heart Devices Market

> Japan Structural Heart Devices Market Research Report: By Type (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.51%
- **2024:** $ 48.12 Million
- **2025:** $ 51.74 Million
- **2035:** $ 106.75 Million
- **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US)

**Report ID:** MRFR/HC/55137-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/japan-structural-heart-devices-market-56903

---

## Market Summary

## **Japan Structural Heart Devices Market Overview****:**

As per MRFR analysis, the Japan Structural Heart Devices Market Size was estimated at 44.38 (USD Million) in 2024.The Japan Structural Heart Devices Market Industry is expected to grow from 48.12(USD Million) in 2025 to 109 (USD Million) by 2035. The Japan Structural Heart Devices Market CAGR (growth rate) is expected to be around 7.715% during the forecast period (2025 - 2035).

### **Key Japan Structural Heart Devices Market Trends Highlighted**

The Japan Structural Heart Devices Market is experiencing notable trends driven primarily by an aging population and rising incidences of cardiovascular diseases in the country. The Japanese government has been proactive in promoting healthcare initiatives and funding for medical technologies that address heart conditions, which is a significant market driver. This focus on improving healthcare infrastructure supports the ongoing development and acceptance of innovative structural heart devices. 

Additionally, heightened awareness regarding heart health among the Japanese population has increased the demand for effective treatment options. Recent trends highlight the growth of minimally invasive procedures for heart ailments, as they offer quicker recovery times and reduced risks for patients.This shift towards less invasive options is particularly relevant in Japan's healthcare landscape, where there is a strong emphasis on patient safety and comfort. 

Technological advancements in device design, such as improved implantable devices and the use of biocompatible materials, are also key factors shaping the market. Opportunities abound in the Japanese market as manufacturers look to expand their product offerings to encompass more advanced and varied options for patients.

Collaborative research efforts between local medical institutions and device manufacturers provide avenues for developing tailored solutions that meet the specific needs of the Japanese population.Overall, the ongoing commitment to healthcare innovation and improvements in treatment practices positions Japan as a fertile ground for the growth of structural heart devices, driving the market forward in the coming years.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Japan Structural Heart Devices Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases**

The rising prevalence of cardiovascular diseases (CVDs) in Japan is a significant driver for the Japan [Structural Heart Devices Market](../../../reports/structural-heart-devices-market-6385) Industry. According to the Ministry of Health, Labour and Welfare, over 10 million individuals in Japan are reported to be living with some form of heart disease, particularly conditions requiring structural heart interventions such as valve diseases and congenital heart defects. 

The Japan Heart Foundation has projected that this number is expected to rise in the coming years due to the aging population and lifestyle-related changes.With the increased burden of CVDs, there is an urgent need for advanced treatment options, which drives the demand for structural heart devices. Established companies like Abbott and Medtronic are actively investing in innovative solutions, thus enhancing the market growth prospects. Their research and development initiatives focus on creating less invasive, efficient, and effective devices to treat these prevalent conditions, thereby meeting the rising needs of patients in Japan.

### **Technological Advancements in Heart Devices**

Technological advancements are transforming the Japan Structural Heart Devices Market Industry, providing new opportunities for market growth. The introduction of minimally invasive procedures and devices, such as transcatheter aortic valve replacement (TAVR) and mitral valve repair systems, enhances patient outcomes and reduces recovery times. The Japan Society of Mechanical Engineers reports that over 70% of interventional cardiologists are adopting these innovative techniques, demonstrating a clear trend toward advanced therapeutic options.Companies like Boston Scientific and Edwards Lifesciences are the forefront of these technologies, investing significantly in research and development to expand their product lines.

As these technological advancements become more mainstream, the demand for structural heart devices is projected to surge in Japan.

### **Growing Elderly Population**

Japan has one of the world's fastest-aging populations, with a significant percentage of individuals aged 65 or older. The National Institute of Population and Social Security Research indicates that by 2025, about 30% of Japan's population will be senior citizens. This demographic shift is directly correlated with an increase in age-related heart conditions, which necessitates structural heart interventions.

As the healthcare system evolves, there is a burgeoning demand for specialized devices that cater to the elderly population experiencing structural heart issues.Large companies, like Terumo Corporation, are working on providing more specialized services for their clients, thus widening the Japan Structural Heart Devices Market. The market will benefit from the dual dynamics of a growing older population alongside specialized medicine.

### **Healthcare Policy Reforms and Increased Investment**

Japan's government is implementing healthcare policy reforms aimed at improving cardiovascular care, significantly impacting the Japan Structural Heart Devices Market Industry. Initiatives such as the Comprehensive Strategy for Cardiac Health, launched by the Ministry of Health, Labour and Welfare, emphasize early diagnosis and treatment of heart diseases, fostering a conducive environment for investment in structural heart devices.

Government investment in healthcare reached a record high, projected to exceed 44 trillion yen by 2025, which provides robust financial backing for the development and distribution of advanced medical technologies.This favorable regulatory framework encourages manufacturers and innovators to bring new devices to the market, thus amplifying growth opportunities in the Japan Structural Heart Devices Market.

## **Japan Structural Heart Devices Market Segment Insights****:**

### **Structural Heart Devices Market Type Insights**

The Japan Structural Heart Devices Market, particularly categorized by its Type, has shown a diverse range of products catering to various cardiovascular conditions. Heart Valve Devices hold a significant position in the market, primarily due to the increasing prevalence of heart diseases and the aging population in Japan. As Japan has one of the highest life expectancies worldwide, the demand for effective heart valve replacements and repairs is critical, given that these devices can enhance the quality of life for patients suffering from valvular heart diseases.

Annuloplasty Rings are integral in the structural heart segment as they offer a necessary solution for mitral and tricuspid valve repair by ensuring optimal valve function post-surgery. The minimally invasive nature of these rings helps reduce recovery time, which is appealing in today's healthcare landscape focused on patient outcomes and cost reduction. 

Occluders have been gaining traction as they prevent blood from flowing into the left atrium in patients with atrial septal defectshus reducing the risk of strokethis aspect is particularly vital given the rising incidence of such ailments in the elderly population.Delivery Systems are essential for the effective deployment of structural heart devices, ensuring that the procedures can be performed with minimal risk and high precision. 

Their development reflects the ongoing advancements in technology, allowing for improved access during catheter-based procedures. Collectively, these categories illustrate a robust landscape for innovation, with many opportunities for growth driven by changing demographics and technological advancements in Japan's healthcare sector, aiming to better address the rising demands for structural heart interventions.Each Type segment serves a crucial role within the overarching scope of the Japan Structural Heart Devices Market, as they contribute not only to device efficacy but also to improved surgical safety and patient satisfaction.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Structural Heart Devices Market Indication Insights**

The Japan Structural Heart Devices Market, particularly in the indication segment, exhibits promising growth propelled by the rising prevalence of cardiovascular diseases, including Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease is significant due to its impact on morbidity and mortality in Japan, where increasing aging population trends contribute to a higher incidence of this condition. Innovative treatment options and advancements in minimally invasive procedures are enhancing patient outcomes. 

Similarly, Cardiomyopathy is a critical area, as it affects a substantial number of individuals, leading to heart failure and necessitating early intervention.The growing emphasis on early diagnosis and effective management strategies enhances the demand for advanced structural heart devices. Furthermore, the Japanese government supports healthcare initiatives aimed at addressing cardiovascular health challenges, creating an environment conducive to market expansion. Overall, these indications reflect a shifting focus in the Japan Structural Heart Devices Market, emphasizing innovation and improved patient care to meet the complex needs of this population.

### **Structural Heart Devices Market Procedure Insights**

The Japan Structural Heart Devices Market is experiencing notable developments, particularly in the Procedure segment, which encompasses various critical interventions within cardiovascular healthcare. Replacement Procedures and Repair Procedures are pivotal in enhancing patient outcomes for those with structural heart diseases. Replacement Procedures typically involve the implantation of devices such as heart valves, which are essential for restoring proper heart function, especially in an aging population where the incidence of heart-related issues is rising.

On the other hand, Repair Procedures focus on correcting malformations or damages in the heart structures, thereby preventing further complications and improving the quality of life. The technological advancements in minimally invasive techniques are driving growth in this segment, providing patients with safer and less painful options compared to traditional surgery.

The growing prevalence of heart diseases in Japan, coupled with increased awareness and early diagnosis, creates substantial growth opportunities for the Procedure segment in the Japan Structural Heart Devices Market.Moreover, the support from government health initiatives and a well-established healthcare infrastructure further solidifies the importance of these procedures in treating structural heart conditions effectively.

## **Japan Structural Heart Devices Market Key Players and Competitive Insights****:**

In the Japan Structural Heart Devices Market, the competitive landscape is characterized by a mix of established players and emerging companies striving to innovate and enhance their product offerings. This market segment has seen significant interest due to the rising prevalence of structural heart diseases, which necessitate advanced medical interventions. 

Companies in this market focus on developing sophisticated devices that cater to a diverse range of conditions, such as atrial septal defects, patent foramen ovale, and valve disorders. The competitive dynamics involve not only traditional competition but also collaborations and partnerships aimed at leveraging technological advancements and improving patient outcomes. Regulatory compliance and a deep understanding of local healthcare frameworks play crucial roles in the strategies adopted by these market participants. Medtronic holds a strong position in the Japan Structural Heart Devices Market, owing to its extensive range of innovative products and substantial investment in research and development. 

The company's commitment to improving cardiovascular health has led it to introduce various cutting-edge devices tailored to the unique needs of the Japanese population. Medtronic's strengths lie in its robust distribution network, strong relationships with healthcare providers, and ongoing clinical trials that enhance its product credibility. The company has strategically expanded its presence in the Japanese market through targeted efforts to address local healthcare challenges. 

Medtronic also actively engages in educational initiatives for healthcare professionals to promote awareness and understanding of its structural heart device offerings, further solidifying its dominant position in this specialized market.Nippon Kayaku has made notable strides in the Japan Structural Heart Devices Market, recognized for its innovative medical solutions and diverse portfolio of key products. The company focuses on developing advanced cardiac devices specifically designed for the local market, catering to various heart conditions with precision-engineered solutions. 

Nippon Kayaku's market presence is bolstered by its strong relationships with healthcare institutions and continuous investment in research that allows for the introduction of innovative technologies tailored the Japanese healthcare system. The company's strengths are derived from its commitment to quality, extensive clinical data supporting its products, and ongoing engagement in collaborations that aim to enhance the efficacy and accessibility of its devices. Additionally, Nippon Kayaku has explored strategic partnerships and potential mergers to amplify its reach and capabilities within the market, thus positioning itself as a formidable player in the structural heart devices sector in Japan.

### **Key Companies in the Japan Structural Heart Devices Market Include:**

- Medtronic
- Nippon Kayaku
- Terumo
- AtriCure
- Janssen Pharmaceuticals
- Cardiac Dimensions
- Getinge
- Boston Scientific
- Abbott
- Novartis
- Toshiba
- LivaNova
- Stereotaxis
- Edwards Lifesciences
- Johnson & Johnson

## **Japan Structural Heart Devices Market Industry Developments**

The Japan Structural Heart Devices Market has recently seen significant developments. Notably, in August 2023, Medtronic announced the launch of its new heart valve therapy system specifically tailored for the Japanese market, aiming to address the rising prevalence of structural heart diseases. Meanwhile, in July 2023, Terumo launched a cutting-edge catheter that enhances precision in treating heart conditions, reflecting the increasing focus on technological innovation. 

There have also been discussions around mergers, as Boston Scientific and AtriCure have shown interest in potential collaborations to strengthen their offerings in cardiac therapies. In the valuation landscape, the market has grown steadily, with a reported increase of 5.7% in market size from January 2022 to January 2023, influenced by the aging population in Japan and rising healthcare expenditures. Furthermore, Johnson and Johnson's acquisition of a smaller venture focused on heart pump technology in September 2022 has been a pivotal move, boosting their presence in the market.

Recent trends indicate a shifting focus toward minimally invasive procedures, which align with the larger global movement in the medical device sector. The Japan Structural Heart Devices Market is adapting rapidly to these evolving demands and technological advancements.

## **Japan Structural Heart Devices Market Segmentation Insights**

### **Structural Heart Devices Market Type****Outlook**

- Heart Valve Devices
- Annuloplasty Rings
- Occluders
- Delivery Systems

### **Structural Heart Devices Market Indication****Outlook**

- Valvular Heart Disease
- Cardiomyopathy

### **Structural Heart Devices Market Procedure****Outlook**

- Replacement Procedures
- Repair Procedures

## Market Drivers

### Growing Awareness and Education

There is a notable increase in awareness and education regarding cardiovascular health in Japan, which serves as a catalyst for the structural heart-devices market. Public health campaigns and initiatives by healthcare organizations are effectively informing the population about the risks associated with heart diseases and the available treatment options. This heightened awareness is leading to earlier diagnosis and treatment, thereby increasing the demand for structural heart devices. Furthermore, healthcare professionals are receiving enhanced training on the latest technologies and procedures, which is likely to improve patient outcomes. As more individuals seek medical intervention for heart-related issues, the structural heart-devices market is expected to expand, driven by informed patients and skilled practitioners.

### Increased Healthcare Expenditure

Japan's healthcare expenditure has been on the rise, which is a significant driver for the structural heart-devices market. The government has been investing heavily in healthcare infrastructure and technology to improve patient care and outcomes. In 2025, healthcare spending is expected to reach approximately ¥42 trillion, reflecting a commitment to enhancing medical services. This increase in funding allows for the procurement of advanced medical devices, including those used in structural heart interventions. As hospitals and clinics upgrade their facilities and equipment, the demand for innovative structural heart devices is likely to grow. This trend indicates a robust market environment, where healthcare providers are better equipped to address the needs of patients with cardiovascular diseases.

### Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases in Japan is a primary driver for the structural heart-devices market. According to recent health statistics, cardiovascular diseases account for approximately 30% of all deaths in the country. This alarming trend necessitates advanced medical interventions, including structural heart devices, to manage and treat these conditions effectively. The demand for innovative solutions is further fueled by the aging population, which is more susceptible to heart-related ailments. As healthcare providers seek to improve patient outcomes, investments in structural heart devices are likely to rise, thereby expanding the market. The structural heart-devices market is expected to witness substantial growth as hospitals and clinics adopt these technologies to address the growing burden of cardiovascular diseases.

### Advancements in Minimally Invasive Procedures

Minimally invasive procedures are transforming the landscape of cardiac interventions in Japan, significantly impacting the structural heart-devices market. These techniques offer numerous advantages, including reduced recovery times, lower risk of complications, and shorter hospital stays. As a result, there is a growing preference among both patients and healthcare providers for these innovative approaches. The introduction of advanced structural heart devices, such as transcatheter aortic valve replacements (TAVR) and left atrial appendage closure devices, aligns with this trend. Market data indicates that the adoption of minimally invasive techniques is projected to increase by 20% over the next five years, further driving the demand for structural heart devices. This shift not only enhances patient care but also encourages the development of new technologies within the market.

### Technological Integration in Healthcare Systems

Advanced technologies are significantly influencing the structural heart-devices market in Japan. The adoption of electronic health records (EHRs), telemedicine, and artificial intelligence (AI) is streamlining patient management and enhancing the efficiency of cardiac care. These technologies facilitate better data collection and analysis, allowing for more personalized treatment plans. As healthcare providers increasingly rely on these innovations, the demand for compatible structural heart devices is likely to rise. Market projections suggest that the incorporation of technology in healthcare will grow by 15% annually, further propelling the structural heart-devices market. This trend underscores the importance of technological advancements in improving patient care and outcomes in the realm of cardiovascular health.

## Future Outlook

The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) in Japan is projected to grow at a 7.51% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand.

**New opportunities:**

- Development of minimally invasive surgical techniques for heart valve repair.
- Expansion of telehealth services for remote patient monitoring and follow-up.
- Investment in R&D for innovative biomaterials in device manufacturing.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic investments.

## Segment Insights

### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing)

In the Japan structural heart-devices market, Transcatheter Aortic Valve Replacement (TAVR) holds the largest market share among the various device types, reflecting strong acceptance by healthcare providers and patients. Mitral Valve Repair Devices are gaining traction and rapidly increasing their foothold due to advancements in device design and effectiveness, allowing them to capture the attention of clinicians seeking improved treatment options for mitral valve conditions.

Growth trends indicate that the demand for minimally invasive procedures is driving the market forward, with both TAVR and Mitral Valve Repair Devices experiencing significant enhancement in clinical outcomes. The rise of aging populations with heart ailments is a critical factor, as it increases the need for effective treatments. Furthermore, technological advancements and regulatory approvals are enabling faster adoption of these innovative devices, reinforcing their growth trajectory within the market.

Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging)

Transcatheter Aortic Valve Replacement (TAVR) is the dominant player in the Japan structural heart-devices market, primarily due to its effectiveness in treating aortic stenosis with minimal invasiveness, leading to shorter recovery times and improved patient outcomes. On the other hand, Mitral Valve Repair Devices are emerging as a preferred option for mitral valve disorders, especially with latest advancements that allow for less invasive approaches. This competition between TAVR and Mitral Valve Repair Devices illustrates a significant shift in treatment paradigms, as healthcare professionals increasingly adopt such technologies for better patient care. These devices not only enhance procedural efficiency but also promise to elevate the overall standard of cardiac care in Japan.

### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing)

In the Japan structural heart-devices market, the market share distribution among the procedure types illustrates that minimally invasive approaches are the predominant choice, driven by their associated benefits such as reduced recovery times and lower complications. Conversely, percutaneous and surgical procedures occupy smaller portions of the market, with surgical techniques currently gaining momentum due to advancements in technology and surgical methodologies that enhance their safety and effectiveness.

Growth trends in the Japan structural heart-devices market indicate a robust rise in minimally invasive procedures, propelled by an increasing preference for less invasive surgical options. The emergence of innovative device designs and improvements in procedural techniques are driving this segment forward, while surgical options are experiencing rapid growth rates as healthcare providers increasingly adopt advanced surgical techniques, further diversifying treatment modalities and catering to a broader patient demographic.

Minimally Invasive: Dominant vs. Surgical: Emerging

The minimally invasive segment in the Japan structural heart-devices market is characterized by its dominance, driven by technological innovations that allow for reduced patient trauma and faster recovery. These procedures typically involve smaller incisions and shorter hospital stays, making them the preferred choice for many patients and doctors. On the other hand, the surgical segment, while historically established, is emerging with renewed vigor due to advancements that enhance procedure safety and success rates. Surgical techniques are evolving with the incorporation of robotics and imaging technologies, promoting better outcomes and positioning surgical interventions as competitive alternatives in the evolving landscape of heart-device procedures.

### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing)

In the Japan structural heart-devices market, Aortic Stenosis commands the largest market share, largely driven by the aging population and increasing prevalence of valvular heart diseases. Mitral Regurgitation also represents a significant portion of the market, but its rapid growth can be attributed to advancements in minimally invasive technologies and rising awareness of treatment options.

Growth trends indicate that the demand for Mitral Regurgitation devices is accelerating, reflecting a shift towards innovative therapeutic solutions. Factors such as improved patient outcomes and the introduction of new devices are driving market expansion. Aortic Stenosis will likely remain a dominant segment, although its growth will be paced compared to the surging interest in treating Mitral Regurgitation.

Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging)

Aortic Stenosis, as a dominant segment, benefits from established treatment protocols and a robust range of devices aimed at addressing this critical condition. The devices for Aortic Stenosis often show high success rates, making them a preferred choice among clinicians. Conversely, Mitral Regurgitation is considered an emerging segment due to its rapid innovation and the introduction of advanced interventional strategies. The market for Mitral Regurgitation devices is expanding quickly, driven by the desire for less invasive solutions that promise improved recovery times and outcomes. As technology continues to evolve, Mitral Regurgitation may increasingly challenge the dominance of Aortic Stenosis in the near future.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Japan structural heart-devices market, hospitals account for the largest share of the end-user segment, reflecting their comprehensive capabilities in handling advanced cardiac procedures. Ambulatory surgical centers are rapidly gaining traction, providing a cost-effective alternative with streamlined services, thus increasing their presence within the market. Cardiology clinics, while important, currently hold a smaller share but are beginning to expand their offerings to cater to growing patient needs.

The growth trends in this segment are primarily driven by the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures. Hospitals are leveraging their resources to adopt innovative technologies, while ambulatory surgical centers capitalize on the shift towards outpatient care. Cardiology clinics are also evolving, focusing on specialized care, positioning themselves to compete effectively in the expanding Japan structural heart-devices market.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals serve as the dominant force in the end-user segment, characterized by their extensive infrastructure, experienced personnel, and access to advanced medical technologies. They are equipped to handle complex heart surgeries and have a well-established patient base, which enhances their market position. On the other hand, ambulatory surgical centers represent an emerging segment, offering a more flexible, patient-centric approach to treatment. These centers focus on efficiency and cost-effectiveness, making them attractive for patients seeking less invasive options. Their growth is spurred by an increasing shift towards outpatient care, as patients prefer shorter recovery times and lower costs associated with such treatments. As both segments continue to evolve, they are reshaping the competitive landscape of the Japan structural heart-devices market.

## Competitive Benchmarking

The [structural heart-devices market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) in Japan is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Edwards Lifesciences (US), Medtronic (US), and Terumo Corporation (JP) are at the forefront, each adopting distinct strategies to enhance their market presence. Edwards Lifesciences (US) focuses on innovation, particularly in transcatheter heart valves, while Medtronic (US) emphasizes a broad portfolio that includes both surgical and minimally invasive solutions. Terumo Corporation (JP), leveraging its local manufacturing capabilities, aims to cater to the specific needs of the Japanese market, thereby enhancing its competitive edge. Collectively, these strategies contribute to a moderately fragmented market structure, where innovation and localized approaches are pivotal for success.
Key business tactics employed by these companies include localizing manufacturing and optimizing supply chains to ensure efficiency and responsiveness to market demands. The competitive structure of the market appears to be moderately fragmented, with several key players influencing the overall dynamics. This fragmentation allows for a variety of product offerings, catering to diverse patient needs and preferences, while also fostering a competitive environment that encourages continuous innovation.
In September 2025, Edwards Lifesciences (US) announced the launch of its next-generation transcatheter aortic valve replacement (TAVR) system, which incorporates advanced imaging technology to enhance procedural outcomes. This strategic move is likely to solidify its leadership position in the TAVR segment, as it addresses the growing demand for minimally invasive cardiac procedures in Japan. The integration of cutting-edge imaging technology not only improves patient outcomes but also aligns with the broader trend of digitalization in healthcare.
In October 2025, Medtronic (US) expanded its partnership with a leading Japanese hospital network to enhance the adoption of its cardiac rhythm management devices. This collaboration aims to streamline patient access to innovative therapies, thereby potentially increasing market penetration. By aligning with local healthcare providers, Medtronic is likely to strengthen its foothold in the region, ensuring that its products are readily available to patients in need of advanced cardiac care.
In August 2025, Terumo Corporation (JP) unveiled a new line of structural heart devices designed specifically for the Asian market, emphasizing biocompatibility and ease of use. This strategic initiative reflects Terumo's commitment to addressing regional healthcare challenges and demonstrates its agility in responding to local market needs. By focusing on product development tailored to the unique requirements of the Japanese population, Terumo is positioning itself as a key player in the structural heart-devices market.
As of November 2025, current trends in the competitive landscape include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and patient management. Strategic alliances among key players are increasingly shaping the market, fostering innovation and enhancing supply chain reliability. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on technological advancements and innovative solutions rather than solely on price. This shift underscores the importance of maintaining a robust supply chain and investing in R&D to meet the evolving needs of healthcare providers and patients alike.

## Recent News & Developments

The Japan Structural Heart Devices Market has recently seen significant developments. Notably, in August 2023, Medtronic announced the launch of its new heart valve therapy system specifically tailored for the Japanese market, aiming to address the rising prevalence of structural heart diseases. Meanwhile, in July 2023, Terumo launched a cutting-edge catheter that enhances precision in treating heart conditions, reflecting the increasing focus on technological innovation. 

There have also been discussions around mergers, as Boston Scientific and AtriCure have shown interest in potential collaborations to strengthen their offerings in cardiac therapies. In the valuation landscape, the market has grown steadily, with a reported increase of 5.7% in market size from January 2022 to January 2023, influenced by the aging population in Japan and rising healthcare expenditures. Furthermore, Johnson and Johnson's acquisition of a smaller venture focused on heart pump technology in September 2022 has been a pivotal move, boosting their presence in the market.

Recent trends indicate a shifting focus toward minimally invasive procedures, which align with the larger global movement in the medical device sector. The Japan Structural Heart Devices Market is adapting rapidly to these evolving demands and technological advancements.

## Report Scope

| MARKET SIZE 2024 | 48.12(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 51.74(USD Million) |
| MARKET SIZE 2035 | 106.75(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.51% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) |
| Segments Covered | Type, Procedure Type, Indication, End User |
| Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the structural heart-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the structural heart-devices market in Japan. |
| Countries Covered | Japan |

## Frequently Asked Questions

**Q: What is the current valuation of the Japan structural heart-devices market?**
A: The market valuation was $48.12 Million in 2024.

**Q: What is the projected market size for the Japan structural heart-devices market by 2035?**
A: The market is projected to reach $106.75 Million by 2035.

**Q: What is the expected CAGR for the Japan structural heart-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 7.51% from 2025 to 2035.

**Q: Which companies are the key players in the Japan structural heart-devices market?**
A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific.

**Q: What are the main segments of the Japan structural heart-devices market?**
A: Main segments include Transcatheter Aortic Valve Replacement, Mitral Valve Repair Devices, and Left Atrial Appendage Closure Devices.

**Q: How did the Transcatheter Aortic Valve Replacement segment perform in 2024?**
A: This segment had a valuation ranging from $20.0 Million to $45.0 Million in 2024.

**Q: What is the market performance of Mitral Valve Repair Devices in 2024?**
A: The Mitral Valve Repair Devices segment was valued between $15.0 Million and $30.0 Million in 2024.

**Q: What are the projected values for the Left Atrial Appendage Closure Devices segment by 2035?**
A: This segment is expected to grow to between $8.0 Million and $20.0 Million by 2035.

**Q: Which end users dominate the Japan structural heart-devices market?**
A: Hospitals, Ambulatory Surgical Centers, and Cardiology Clinics are the primary end users.

**Q: What was the valuation of the Surgical procedure type segment in 2024?**
A: The Surgical procedure type segment was valued between $20.0 Million and $40.0 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/japan-structural-heart-devices-market-56903*